Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Bunjes

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantationAntje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Blood Advances|March 20, 2019
Stem cell transplantation for osteopetrosis in patients beyond the age of 5 yearsPolina Stepensky, Sigal Grisariu, Batia Avni, et al.
British Journal of Haematology|August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II studyMark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Frontiers in Immunology|May 14, 2026
Impact of post-transplant cyclophosphamide and anti-thymocyte globulin on immune reconstitution in MUD allo-HCTGiulia Furnari, Verena Wais, Anna Francesio, et al.
Blood|July 9, 2008
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantationFabio Ciceri, Myriam Labopin, Franco Aversa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantationThorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
Frontiers in Immunology|June 8, 2026
Letermovir does not affect long-term polyclonal immune reconstitution after allogeneic hematopoietic stem cell transplantation with ATG-based GvHD prophylaxisConrad Weidt, Adela Maria Neagoie, Maral Saadati, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantationAntje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Blood Advances|March 20, 2019
Stem cell transplantation for osteopetrosis in patients beyond the age of 5 yearsPolina Stepensky, Sigal Grisariu, Batia Avni, et al.
British Journal of Haematology|August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II studyMark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Frontiers in Immunology|May 14, 2026
Impact of post-transplant cyclophosphamide and anti-thymocyte globulin on immune reconstitution in MUD allo-HCTGiulia Furnari, Verena Wais, Anna Francesio, et al.
Blood|July 9, 2008
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantationFabio Ciceri, Myriam Labopin, Franco Aversa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantationThorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Blood|February 18, 2011
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseasesAnsgar S Schulz, Gerhard Glatting, Manfred Hoenig, et al.
Frontiers in Immunology|June 8, 2026
Letermovir does not affect long-term polyclonal immune reconstitution after allogeneic hematopoietic stem cell transplantation with ATG-based GvHD prophylaxisConrad Weidt, Adela Maria Neagoie, Maral Saadati, et al.
Pageof 11